ロード中...
Acquired Resistance to Immune Checkpoint Blockade Therapies
Immune checkpoint blockade therapy (ICBT) has revolutionized the treatment and management of numerous cancers, yet a substantial proportion of patients who initially respond to ICBT subsequently develop resistance. Comprehensive genomic analysis of samples from recent clinical trials and pre-clinica...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280955/ https://ncbi.nlm.nih.gov/pubmed/32380703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051161 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|